Selected article for: "study drug and treatment process"
Author: Xiaolin Yuan; Wanrong Yi; Baoyi Liu; Simiao Tian; Fang Cao; Ruoyu Wang; Baiwen Qi; Faqiang Lu; Meiyun Fang; Fuyang Pei; Ming Chen; Lichuan Zhang; Yong Zhang; Xiuzhi Zhang; Zhenyu Pan; Dewei Zhao; Aixi Yu
Title: Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment
  • Document date: 2020_4_14
    • ID: gzao2fo6_11
    Snippet: In conclusion, in this randomized pilot study, the clinical drug, 99m Tc-MDP had an effective inhibitory effect on the inflammatory disease progression from mild to severe for the therapy of COVID-19, and it can accelerate the absorption of pulmonary inflammation in a short period of time during the process of treatment......
    Document: In conclusion, in this randomized pilot study, the clinical drug, 99m Tc-MDP had an effective inhibitory effect on the inflammatory disease progression from mild to severe for the therapy of COVID-19, and it can accelerate the absorption of pulmonary inflammation in a short period of time during the process of treatment.

    Search related documents:
    Co phrase search for related documents
    • clinical drug and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • clinical drug and mild disease progression: 1
    • clinical drug and pilot study: 1, 2, 3, 4
    • clinical drug and pulmonary inflammation: 1, 2
    • clinical drug and randomized pilot study: 1
    • clinical drug and short period: 1, 2, 3
    • clinical drug and treatment process: 1, 2, 3, 4, 5, 6, 7
    • disease progression and inflammatory mild disease progression: 1, 2
    • disease progression and inhibitory effect: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • disease progression and mild disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease progression and pilot study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • disease progression and pulmonary inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • disease progression and pulmonary inflammation absorption: 1, 2
    • disease progression and pulmonary inflammation absorption accelerate: 1, 2
    • disease progression and randomized pilot study: 1, 2, 3
    • disease progression and short period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • disease progression and time short period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • disease progression and treatment process: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • inflammatory mild disease progression and inhibitory effect: 1